C. Sensenhauser

发表

Cytochrome P450 induction response in tethered spheroids as a three‐dimensional human hepatocyte in vitro model

Hanry Yu, S. Dallas, L. Xia, 2016, Journal of applied toxicology : JAT.

Interleukins-12 and -23 Do Not Alter Expression or Activity of Multiple Cytochrome P450 Enzymes in Cryopreserved Human Hepatocytes

S. Dallas, M. Singer, C. Sensenhauser, 2013, Drug Metabolism and Disposition.

A physiologically based pharmacokinetic modeling approach to predict drug–drug interactions between domperidone and inhibitors of CYP3A4

J. Snoeys, P. Ravenstijn, C. Sensenhauser, 2016, Biopharmaceutics & drug disposition.

In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin

Mark D. Johnson, L. Leclercq, S. Dallas, 2017, British journal of clinical pharmacology.

Characterization of the In Vitro Inhibitory Potential of the Oligonucleotide Imetelstat on Human Cytochrome P450 Enzymes with Predictions of In Vivo Drug-Drug Interactions

F. Kazmi, C. Sensenhauser, T. Greway, 2018, Drug Metabolism and Disposition.

The influence of fluoranthene on the metabolism and DNA binding of benzo[a]pyrene in vivo in mouse skin.

E. LaVoie, J. E. Rice, C. Sensenhauser, 1988, Chemico-biological interactions.

Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer.

Shefali R Patel, K. Bachman, V. Pande, 2021, Journal of medicinal chemistry.

In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity

J. Snoeys, A. Bernard, J. Jiao, 2016, Drug Metabolism and Disposition.

IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES TO ASSESS THE EFFECT OF ABIRATERONE ACETATE , ABIRATERONE , AND METABOLITES OF ABIRATERONE ON CYP 2 C 8 ACTIVITYa

J. Snoeys, A. Bernard, J. Jiao, 2016 .

De-risking bio-therapeutics for possible drug interactions using cryopreserved human hepatocytes.

Honghui Zhou, S. Dallas, M. Markowska, 2012, Current drug metabolism.

Drug Interaction Assessment Strategies: Small Molecules versus Therapeutic Proteins

S. Dallas, José Silva, C. Sensenhauser, 2013 .

In Vitro CYP/FMO Reaction Phenotyping

Carlo Sensenhauser, C. Sensenhauser, 2014 .

A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.

Jie Chen, David C Evans, D. C. Evans, 2008, Rapid communications in mass spectrometry : RCM.

Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate.

K. Rhodes, B. Shook, S. Rassnick, 2011, Chemical research in toxicology.

Metabolite identification by data-dependent accurate mass spectrometric analysis at resolving power of 60,000 in external calibration mode using an LTQ/Orbitrap.

Jie Chen, H. Lim, Heng-Keang Lim, 2007, Rapid communications in mass spectrometry : RCM.

EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES

D. Roymans, P. Annaert, G. Mannens, 2005, Drug Metabolism and Disposition.

In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity

J. Snoeys, J. Jiao, J. Monbaliu, 2016, Drug Metabolism and Disposition.

In Vitro CYP Induction Using Human Hepatocytes

S. Dallas, M. Singer, C. Sensenhauser, 2014 .